Journal
CANCER LETTERS
Volume 166, Issue 1, Pages 71-77Publisher
ELSEVIER SCI IRELAND LTD
DOI: 10.1016/S0304-3835(01)00447-5
Keywords
topoisomerase II; embryonic stem cell; gene targeting; drug resistance; topoisomerase II inhibitor
Categories
Ask authors/readers for more resources
To elucidate the relationship between topoisomerase (topo) II expression and sensitivity to anti-topo II drugs in mammalian cells, we generated mouse embryonic stem cell mutants heterozygous for the lope II alpha gene by gene targeting. The level of topo II alpha in the heterozygous cells reduced to one-half of that found in wild-type cells, while topo II beta levels were similar in both cell types. Importantly, the heterozygous cells exhibited an increased resistance to ICRF-193 as well as VP-16, suggesting that ICRF-193, like VP-16, exerts its cytotoxicity through converting topo II to a poison. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available